Vatalanib Succinate

Known as: 1-[4-Chloroanilino]-4-[4-pyridylmethyl]phthalazine Succinate, Butanedioic Acid, Compd. with N-(4-Chlorophenyl)-4-(4-pyridinylmethyl)-1-phthalazinamine (1:1) 
The succinate salt of vatalanib, an anilinophthalazine derivative, with antineoplastic activity. Vatalanib binds to and inhibits the protein kinase… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2003-2008
01220032008

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Microcrystalline cellulose (MCC) is a well-established pelletisation aid. However, MCC pellets generally do not disintegrate… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2009
2009
The major aim of this study was to identify an efficient tool to adjust drug release patterns from aqueous and organic… (More)
Is this relevant?
2008
2008
A series of novel substituted 1,2,3-benzotriazines based on the structures of vatalanib succinate (PTK787) and vandetanib (ZD6474… (More)
  • figure 1
  • table 1
  • table 2
Is this relevant?
2008
2008
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… (More)
Is this relevant?
2003
2003
Gateways to clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… (More)
Is this relevant?